Brief: Canbridge Pharmaceuticals Says Glenn Hassan Has Tendered His Resignation As Chief Financial Officer
30/09/2024 11:55
Sept 30 (Reuters) - Canbridge Pharmaceuticals 1228.HK :
* GLENN HASSAN HAS TENDERED HIS RESIGNATION AS CHIEF
FINANCIAL
OFFICER
* JAMES QUN XUE WILL ASSUME INTERIM DUTIES AND
RESPONSIBILITIES OF
CFO
Further company coverage: 1228.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CANbridge Pharmaceuticals
See all newsChina's CANbridge Pharmaceuticals H1 revenue rises on Hunterase and Livmarli strength
Brief: CANbridge Pharmaceuticals Posts HY Loss of RMB37.1 MLN
Brief: Canbridge Pharmaceuticals Says Livmarli Obtains NHIA Reimbursement Approval In Taiwan For ALGS And PFIC
Brief: Canbridge Pharmaceuticals Initiates Registration And Launch Preparations For Gaurunning In North African Market
CANbridge Pharmaceuticals jumps as WuXi Biologics buys shares